TOKYO: FUJIFILM Corporation (President and CEO, Representative Director: Teiichi Goto) today announced that FUJIFILM Irvine Scientific, Inc., a world leader in the development and manufacture of serum-free and chemically defined cell culture media for life science research, bioproduction, and cell therapy manufacturing, completed the acquisition of Shenandoah Biotechnology, Inc., a leading manufacturer of recombinant proteins. […]

Life science research distributor Nordic BioSite Group brings in new majority owner Adelis Equity Partners in order to further accelerate its growth and geographic expansion with the goal of becoming an even stronger partner to its suppliers and customers Nordic BioSite Group (NBG) is a leading European supplier of research and diagnostics products, with a […]

SOUTH SAN FRANCISCO, Calif. — NanoTemper Technologies announced today the launch of Spectral Shift technology within their Dianthus instrument, built to handle the most challenging affinity-based screenings in drug discovery. This breakthrough technology removes the roadblocks experienced by scientists dealing with really complex molecular interactions often seen in challenging drugs and drug targets like proteolysis-targeting chimeras […]

HALF MOON BAY, Calif. – Life Science Newswire – GenNext Technologies, Inc., a growth-stage company providing biopharmaceutical drug discovery systems and services, announced today the receipt of a two year, Phase II SBIR grant for a project titled “In-Cell Automated Flash Oxidation (IC-AutoFox™) Protein Footprinting System.” The grant was awarded by the National Institute of […]

Acquisition offers customers worldwide a single point of access for cGMP cell culture solutions for biopharmaceuticals, and cell and gene therapies TOKYO: FUJIFILM Corporation (President and CEO, Representative Director: Teiichi Goto) today announced that FUJIFILM Irvine Scientific, Inc., a world leader in the development and manufacture of serum-free and chemically defined cell culture media for […]

AMSBIO has introduced further essential tools for SARS-CoV-2 researchers to help decipher the COVID-19 B.1.1.529 variant. New to the AMSBIO range are recombinant proteins, easy-to-perform assay kits, Omicron pseudotyped lentiviruses and spike neutralizing antibodies for use in functional assays to block SARS-CoV-2 spike protein and ACE2 binding. Screening for small molecule and antibody inhibitors is an important […]

BOSTON — ABclonal Technology, a rapidly growing life science research and diagnostic reagents manufacturer, today announced it has joined the Industry Advisory Committee (IAC) at YCharOS Inc., an open science company with the mission of characterizing commercially available antibody reagents for all human proteins, to tackle the reproducibility crisis observed in biomedical research. Inconsistent antibody […]

BOULDER, Colo. — SomaLogic (NASDAQ: SLGC), a leader in data-driven proteomics technology, today announced that the company will begin assaying samples from the European Prospective Investigation into Cancer and Nutrition (EPIC) study beginning in the first quarter of 2022. SomaLogic will use its industry leading SomaScan® Assay to analyze 210 million protein measurements from 30,000 samples […]

Combination of Biosynth Carbosynth and vivitide creates global life sciences platform serving high-growth biopharma and diagnostics end markets London – KKR, a leading global investment firm, announced today the closing of its previously announced investment in Biosynth Carbosynth, an innovative life sciences reagents, custom synthesis and manufacturing services company, as well as Biosynth Carbosynth’s acquisition of vivitide, […]

Relocation driven by increased demand for Vector Laboratories’ growing areas of focus, glycomics and proteomics Vector Laboratories, the pioneer of innovative proteomic and glycomic solutions, today opened its new facility in Newark, California, where it will relocate its corporate headquarters this year. The relocation is accompanied by the rebranding and launch of a new corporate […]